Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

Published: Nov. 14, 2023, 11 a.m.

b'The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.\\nRead this story here.\\nLearn more about your ad choices. Visit podcastchoices.com/adchoices'